+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antimicrobial Resistance Diagnostic Market by Technology, Product, Test Type, End User, Application, Sample Type, Pathogen - Global Forecast to 2030- Product Image
Antimicrobial Resistance Diagnostic Market by Technology, Product, Test Type, End User, Application, Sample Type, Pathogen - Global Forecast to 2030- Product Image
Sale

Antimicrobial Resistance Diagnostic Market by Technology, Product, Test Type, End User, Application, Sample Type, Pathogen - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014956
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antimicrobial resistance diagnostics market is rapidly evolving, driven by urgent clinical needs and advancing technologies. Senior decision-makers recognize the sector’s growing importance as precision, speed, and reliability take center stage in combating resistant infections.

Market Snapshot: Antimicrobial Resistance Diagnostic Market

The Antimicrobial Resistance Diagnostic Market grew from USD 4.75 billion in 2024 to USD 5.07 billion in 2025. It is expected to continue growing at a CAGR of 6.35%, reaching USD 6.88 billion by 2030. Heightened awareness regarding resistant pathogens and investment in cutting-edge technologies are accelerating market demand, particularly among clinical laboratories and healthcare providers aiming to deliver timely interventions. These trends underscore strong growth momentum as global healthcare systems adapt to the changing diagnostic landscape.

Scope & Segmentation

This research provides a comprehensive analysis of the Antimicrobial Resistance Diagnostics Market across multiple strategic filters. The market’s breadth is defined by a wide array of segments, enabling stakeholders to align investments and resources more effectively:

  • Technology Types: Mass spectrometry, microarray, next generation sequencing (both long and short read sequencing), and polymerase chain reaction (PCR) platforms form the foundation of today’s diagnostic innovation.
  • Product Categories: Instruments represent high-value capital investments; reagents and consumables are essential for recurring workflows; software and services facilitate integration and ensure ongoing operational support.
  • Test Type: Genotypic methods encompass targeted assays and whole genome sequencing, while phenotypic tests offer direct assessment of microbial growth under antimicrobial exposure.
  • End Users: Academic and research institutions, diagnostic centers, hospitals, clinics, and reference laboratories each drive adoption through unique priorities.
  • Application Focus: Human diagnostics, pharmaceutical and biopharmaceutical applications, and veterinary diagnostics cover key demand areas, addressing both clinical and zoonotic concerns.
  • Sample Types: Blood, respiratory, urine, and wound specimens are primary sources for pathogen detection and resistance profiling.
  • Pathogen Segments: Fungi, gram negative bacteria, and gram positive bacteria comprise core target classes within the market.
  • Regional Coverage: Americas (with deep dives into major U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East and Africa (including key European, Middle Eastern, and African countries), and Asia-Pacific (notably China, India, Japan, Australia, and key Southeast Asian markets).
  • Key Companies: Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, bioMérieux SA, Danaher Corporation, Becton, Dickinson and Company, QIAGEN, Siemens Healthineers, Bruker Corporation, and Bio-Rad Laboratories.

Key Takeaways for Decision-Makers

  • Integrated technology ecosystems are becoming essential, with molecular and analytical platforms now routinely combined to optimize diagnostic accuracy and workflow efficiency.
  • Cloud-based data sharing and machine learning are transforming diagnostic interpretation, delivering actionable clinical insights while enabling proactive responses to resistance trends.
  • Strategic supplier diversification and regional production hubs are gaining traction to buffer against procurement challenges and potential disruptions in the global supply chain.
  • Expansion of decentralized testing protocols is enabling broader access in diverse healthcare settings, especially where resources or infrastructure are limited.
  • Collaborative industry initiatives are solidifying regulatory pathways, standardized protocols, and interoperability benchmarks, driving greater scalability across markets.

Tariff Impact on Market Dynamics

Recent tariff measures in the United States are reshaping procurement and cost models within the antimicrobial resistance diagnostics sector. Diagnostic manufacturers are reevaluating sourcing strategies and, where possible, localizing production to ensure continuity of supply and reduce tariff exposure. Laboratories have responded by implementing agile inventory management and negotiating long-term supplier agreements, while industry associations advocate for balanced policies preserving innovation and ensuring medical technology access.

Methodology & Data Sources

This report integrates primary research from structured interviews with industry experts, including microbiologists, laboratory directors, and regulatory professionals. Secondary research involved analysis of peer-reviewed journals, regulatory filings, patent databases, vendor disclosures, and proprietary data sets. Market segmentation and trends were validated by triangulating multiple data sources to maintain consistency and accuracy.

Why This Report Matters

  • Supports strategic investment by providing granular segmentation and actionable insight across critical market dimensions.
  • Equips senior leaders with foresight on technology integration, regulatory shifts, and effective operational strategies for resilient growth.
  • Delivers a balanced perspective on regional opportunities, supplier dynamics, and innovation levers shaping future market trajectories.

Conclusion

The antimicrobial resistance diagnostics market is progressing on the strength of evolving technologies and dynamic regulatory environments. Stakeholders leveraging integrated solutions and adaptive sourcing will be best positioned to address emerging clinical and operational challenges in this vital sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antimicrobial Resistance Diagnostic Market, by Technology
8.1. Introduction
8.2. Mass Spectrometry
8.3. Microarray
8.4. Next Generation Sequencing
8.4.1. Long Read Sequencing
8.4.2. Short Read Sequencing
8.5. Polymerase Chain Reaction (PCR)
9. Antimicrobial Resistance Diagnostic Market, by Product
9.1. Introduction
9.2. Instruments
9.3. Reagents & Consumables
9.4. Software & Services
9.4.1. Services
9.4.1.1. Consulting Services
9.4.1.2. Support Services
9.4.2. Software
10. Antimicrobial Resistance Diagnostic Market, by Test Type
10.1. Introduction
10.2. Genotypic Tests
10.2.1. Targeted Assays
10.2.2. Whole Genome Sequencing
10.3. Phenotypic Tests
11. Antimicrobial Resistance Diagnostic Market, by End User
11.1. Introduction
11.2. Academic & Research Institutions
11.3. Diagnostic Centers
11.4. Hospitals & Clinics
11.5. Reference Laboratories
12. Antimicrobial Resistance Diagnostic Market, by Application
12.1. Introduction
12.2. Human Diagnostics
12.3. Pharmaceutical & Biopharmaceutical
12.4. Veterinary Diagnostics
13. Antimicrobial Resistance Diagnostic Market, by Sample Type
13.1. Introduction
13.2. Blood Samples
13.3. Respiratory Samples
13.4. Urine Samples
13.5. Wound Swabs
14. Antimicrobial Resistance Diagnostic Market, by Pathogen
14.1. Introduction
14.2. Fungi
14.3. Gram Negative Bacteria
14.4. Gram Positive Bacteria
15. Americas Antimicrobial Resistance Diagnostic Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Antimicrobial Resistance Diagnostic Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Antimicrobial Resistance Diagnostic Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Roche Diagnostics
18.3.2. Abbott Laboratories
18.3.3. Thermo Fisher Scientific Inc.
18.3.4. bioMérieux SA
18.3.5. Danaher Corporation
18.3.6. Becton, Dickinson and Company
18.3.7. QIAGEN N.V.
18.3.8. Siemens Healthineers AG
18.3.9. Bruker Corporation
18.3.10. Bio-Rad Laboratories, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET MULTI-CURRENCY
FIGURE 2. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET MULTI-LANGUAGE
FIGURE 3. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024 VS 2030 (%)
FIGURE 20. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LONG READ SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SHORT READ SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TARGETED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PHENOTYPIC TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY HUMAN DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY WOUND SWABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FUNGI, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GRAM NEGATIVE BACTERIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GRAM POSITIVE BACTERIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 72. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 74. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 76. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 77. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 79. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 83. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 85. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 87. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 139. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 141. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 143. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 144. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 145. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 146. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 150. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 152. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 154. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 155. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 156. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 157. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 160. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 172. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 174. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 176. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 177. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 178. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 179. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 182. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 183. SPAIN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. SPAIN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 185. SPAIN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. SPAIN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 187. SPAIN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 188. SPAIN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 189. SPAIN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 190. SPAIN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. SPAIN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. SPAIN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 193. SPAIN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 227. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 229. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 231. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 232. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 233. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 234. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 237. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 249. QATAR ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. QATAR ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 251. QATAR ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. QATAR ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 253. QATAR ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 254. QATAR ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 255. QATAR ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 256. QATAR ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. QATAR ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. QATAR ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 259. QATAR ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 260. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 262. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 263. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 264. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 265. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 266. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 267. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 270. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
TABLE 293. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antimicrobial Resistance Diagnostic market report include:
  • Roche Diagnostics
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Danaher Corporation
  • Becton, Dickinson and Company
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Bruker Corporation
  • Bio-Rad Laboratories, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.88 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antimicrobial Resistance Surveillance Market by Offering, Technology, Application, End User - Global Forecast to 2030 - Product Image

Antimicrobial Resistance Surveillance Market by Offering, Technology, Application, End User - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report by Technology (Microbiology Culture, PCR), End-use (Hospitals, Diagnostic Laboratories), Pathogen, Region, and Segment Forecasts, 2025-2030 - Product Image

Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report by Technology (Microbiology Culture, PCR), End-use (Hospitals, Diagnostic Laboratories), Pathogen, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Antimicrobial Resistance Surveillance - Global Strategic Business Report - Product Image

Antimicrobial Resistance Surveillance - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
Antimicrobial Resistance Diagnostics - Global Strategic Business Report - Product Image

Antimicrobial Resistance Diagnostics - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Antibiotic Resistance Market by Product Type, Test Type, Application, End Use, Resistance Mechanism - Global Forecast to 2030 - Product Image

Antibiotic Resistance Market by Product Type, Test Type, Application, End Use, Resistance Mechanism - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.